Business Segments Pfizer Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 15:51:57 22/07/2026 BST			5-day change	1st Jan Change
25.02 ^USD	+0.34%		+0.95%	+0.63%

07-19	Pfizer Inc. Submits Notification of Proposed Production Activity to Ftz Board for Facilities in Kalamazoo and Portage, Michigan	CI
07-17	AI's Blank Check Is Bouncing

Breakdown by Business Segment (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Products
Global Biopharmaceuticals Business (Biopharma)	79.56B	98.99B	57.19B	62.4B	61.2B
Interest Expense	-	-	-	-	-
Income Tax Expense	-	-	-	-	-
Total Assets	-	-	-	-	-
CAPEX	-	-	-	-	-
EBT	40.23B	57.15B	30.63B	28.14B	29.34B
D&A	1.44B	813M	882M	1.36B	1.38B
Net Income	-	-	-	-	-
Upjohn	-	-	-	-	-
EBT	-	-	-	-	-
D&A	-	-	-	-	-
Innovative Health (IH)	-	-	-	-	-
EBT	-	-	-	-	-
D&A	-	-	-	-	-
Essential Health (EH)	-	-	-	-	-
EBT	-	-	-	-	-
D&A	-	-	-	-	-
Life Sciences Tools and Services
Pfizer Centreone (PC1)	-	-	-	1.15B	1.34B
Pfizer Ignite	-	-	-	82M	41M
D&A	-	3.61B	4.73B	5.29B	4.87B
D&A	3.07B	-	-	-	-
EBT	-	-3.61B	-4.73B	-5.29B	-4.87B
D&A	-	-20M	-11M	12M	-4M
EBT	-3.18B	-	-	-	-
D&A	87M	36M	-	-	38M
EBT	-52M	-832M	-1.87B	-1.94B	-1.28B
D&A	-	-	-	-	-
EBT	-2.29B	-3.61B	-3.92B	-5.51B	-7.46B
EBT	-	-	-	-	-
D&A	-	-	-	-	-
EBT	-	-	-	-	-
D&A	-	-	-	-	-
EBT	-	-	-	-	-
Pharmaceutical Contract Manufacturing Services
Other business activities	1.73B	1.34B	1.31B	-	-
EBT	-10.4B	-14.37B	-19.05B	-7.38B	-8.2B
D&A	598M	626M	654M	340M	305M

Geographical breakdown of sales (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	29.75B	42.47B	27.09B	38.69B	37.08B
Total Assets	8.38B	9.18B	10.67B	9.75B	9.68B
Developed Markets	-	-	-	16.06B	16.19B
Total Assets	-	-	-	7.19B	8.18B
Emerging Markets	20.7B	20.1B	12B	8.88B	9.31B
Total Assets	1.06B	1.41B	1.76B	1.46B	1.46B
Developed Europe	18.34B	21.98B	11.65B	-	-
Total Assets	5.09B	5.39B	6.22B	-	-
International	12.51B	15.78B	7.76B	-	-
Total Assets	347M	293M	290M	-	-